Vol. 8, Issue 12 (2019)

Materials and Methods: Over the course of 18 months, 120 children with adenoid hypertrophy participated in this prospective comparative study. This study was conducted at the department of ENT, I-Care Institute of Medical Sciences and Research, Haldia, West Bengal, India from July 2018 to June 2019. Two groups were randomly assigned to the patients: There were 60 patients in Group A who had curettage for a conventional adenoidectomy. Members of Group B (n = 60) had adenoidectomy procedures that were aided by endoscopes. Time to resume regular food, recurrence rates, remaining adenoid tissue, intraoperative haemorrhage, postoperative discomfort (VAS score), and time to reopen nasal passages were all recorded during a 6-month follow-up.

Results: Although EAMA required a slightly longer amount of time to perform the operation, the advantages of increased precision, decreased complications, and greater symptom relief more than compensated for this brief disadvantage. A considerable reduction in intraoperative haemorrhage, a decrease in the amount of residual adenoid tissue, a reduction in postoperative pain, and a speedier recovery were all observed using EAMA. The rate of recurrence was reduced in EAMA, and the clearance of nasal obstruction was higher in this category.

Conclusion: A safer and more effective alternative to traditional adenoidectomy, endoscopically assisted micro-debrider adenoidectomy (EAMA) provides improved surgical precision, reduced intraoperative bleeding, faster recovery, and lower recurrence rates. All things considered, EAMA is the way to go when it comes to adenoidectomy in kids. To validate these results and evaluate long-term effects, additional large-scale investigations are suggested.